Calvin Chih-chia Wu, MD | |
2204 Grant Rd Ste 103, Mountain View, CA 94040-3877 | |
(650) 967-8841 | |
Not Available |
Full Name | Calvin Chih-chia Wu |
---|---|
Gender | Male |
Speciality | Endocrinology |
Experience | 13 Years |
Location | 2204 Grant Rd Ste 103, Mountain View, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659646891 | NPI | - | NPPES |
113813 | Other | CA | SID # 113813 |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | A122403 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Carbon Health Primary Care Of California Pc | 8628350626 | 38 |
News Archive
Biomedical research in Arkansas has received a $14.7 million boost over five years from the National Institutes of Health (NIH) to continue expanding and improving biomedical research in the state.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
Cardiovascular health and physical activity levels of prostate cancer patients improve following successful interventions by community pharmacies, new research in the British Medical Journal reports.
Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.
Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work had to be done manually.
› Verified 7 days ago
Entity Name | Leonard Doberne |
---|---|
Entity Type | Practitioner - Internal Medicine |
Entity Identifiers | NPI Number: 1558447847 PECOS PAC ID: 2860597416 Enrollment ID: I20070410000604 |
News Archive
Biomedical research in Arkansas has received a $14.7 million boost over five years from the National Institutes of Health (NIH) to continue expanding and improving biomedical research in the state.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
Cardiovascular health and physical activity levels of prostate cancer patients improve following successful interventions by community pharmacies, new research in the British Medical Journal reports.
Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.
Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work had to be done manually.
› Verified 7 days ago
Entity Name | Carbon Health Primary Care Of California Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972057990 PECOS PAC ID: 8628350626 Enrollment ID: O20170127001216 |
News Archive
Biomedical research in Arkansas has received a $14.7 million boost over five years from the National Institutes of Health (NIH) to continue expanding and improving biomedical research in the state.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
Cardiovascular health and physical activity levels of prostate cancer patients improve following successful interventions by community pharmacies, new research in the British Medical Journal reports.
Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.
Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work had to be done manually.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Calvin Chih-chia Wu, MD 2204 Grant Rd, Ste 103, Mountain View, CA 94040-3877 Ph: (323) 226-7556 | Calvin Chih-chia Wu, MD 2204 Grant Rd Ste 103, Mountain View, CA 94040-3877 Ph: (650) 967-8841 |
News Archive
Biomedical research in Arkansas has received a $14.7 million boost over five years from the National Institutes of Health (NIH) to continue expanding and improving biomedical research in the state.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
Cardiovascular health and physical activity levels of prostate cancer patients improve following successful interventions by community pharmacies, new research in the British Medical Journal reports.
Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.
Screening blood donations and molecular diagnostics for patients started in the nineties. At the beginning, the level of automation in molecular diagnostic testing was limited; most of the work had to be done manually.
› Verified 7 days ago
Sevwandi De Silva, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7144 | |
Dr. Gayathri Thiru, M.D Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2490 Hospital Drive, Suite 212, Mountain View, CA 94040 Phone: 408-900-8077 Fax: 844-965-9436 | |
Dr. Shawn Mathew Jacob, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2500 Grant Rd, Mountain View, CA 94040 Phone: 650-940-7000 | |
Dr. Vibha Ramaswamy Iyengar, M.D, MPH Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7808 | |
Geoffrey Yoon, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-404-8300 | |
Dr. David Alan Reinert, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7000 | |
Apurva Marfatia, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Medical Staff, Mountain View, CA 94040 Phone: 650-934-7144 |